Application of diagnostic marker for newborn biliary atresia
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HUMAN METABOLOMICS INST INC
- Publication Date
- 2021-05-04
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of biomedical technology, in particular to a diagnostic marker that can be used to assess the risk of neonatal biliary atresia and its application in the field of monitoring, screening and diagnosis of neonatal biliary atresia, and the present invention also relates to the detection of the diagnostic marker Methods and Apparatus. Background technique
[0002] Biliary atresia (BA) is a progressive, idiopathic extrahepatic biliary system disease that occurs in the neonatal period and is a devastating neonatal inflammatory fibrous obstruction of the bile ducts affecting intrahepatic and extrahepatic bile ducts of varying lengths, It is the most common cause of neonatal obstructive jaundice and the most common cause of pediatric liver transplantation. About 60% of children's liver transplantation is caused by this. If children diagnosed with congenital biliary atresia are not treated in time, more than 80% will d...